𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis C

✍ Scribed by Michael von Wagner; Miriam Huber; Thomas Berg; Holger Hinrichsen; Jens Rasenack; Tobias Heintges; Alexandra Bergk; Christine Bernsmeier; Dieter Häussinger; Eva Herrmann; Stefan Zeuzem

Book ID
119758583
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
173 KB
Volume
129
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized comparison of 12 or 24 weeks
Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection
✍ Martin Lagging; Nina Langeland; Court Pedersen; Martti Färkkilä; Mads Rauning Bu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

Previous trials investigating the efficacy of treatment durations shorter than the standard of 24 weeks for chronic hepatitis C virus (HCV) genotype 2/3 infections have yielded discordant results. The aims of this investigator-initiated phase III study were to compare the efficacy of 12 or 24 weeks

Identifying hepatitis C virus genotype 2
Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin
✍ Moises Diago; Mitchell L. Shiffman; Jean-Pierre Bronowicki; Stefan Zeuzem; Marib 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

The objective of this analysis was to compare sustained virological response (SVR) and relapse rates in patients with a rapid virological response (RVR, HCV RNA <50 IU/mL at week 4) randomized to 24 or 16 weeks of treatment with peginterferon alfa-2a (40KD) 180 microg/week plus ribavirin 800 mg/day

Peginterferon alfa-2a (40 kd) and ribavi
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1
✍ Lennox J. Jeffers; William Cassidy; Charles D. Howell; Sylvia Hu; K. Rajender Re 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Black Americans (blacks) have a high prevalence of chronic hepatitis C virus (HCV) infection and respond poorly to therapy with interferon alfa-based regimens, but they have been underrepresented in clinical trials. The aim of this study was to assess the rate of sustained virological response (SVR)

Peginterferon alfa-2a (40 kd) and ribavi
Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1
✍ Michal R. Pijak; Frantisek Gazdik; Stefan Hrusovsky 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

An interesting report by Streetz et al. published in HEPATOLOGY described the production of hepatocyte conditional gp130 knockout mice subjected to chronic liver injury by repeated carbon tetrachloride (CCl 4 ) treatment. 1 Chronic injury induces liver regeneration by recruitment of cells from a pre